Patience David 4
4 · Accelerate Diagnostics, Inc · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Patience David
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-01$0.71/sh−6,816$4,839→ 64,568 total - Exercise/Conversion
Common Stock
2025-04-01+20,000→ 71,384 total - Exercise/Conversion
Employee Restricted Stock Units
2025-04-01−20,000→ 30,000 total→ Common Stock (20,000 underlying)
Holdings
- 760(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
- [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F3]On April 1, 2023, the reporting person was granted a total of 50,000 RSUs, of which 40% vest on April 1, 2025 and the remaining 60% vest on April 1, 2026.